Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|19|12|1021-1041

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.19, Iss.12, 2018-10, pp. : 1021-1041

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up

By  

Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. : 2793-2802

Bentham Science Publishers

Access to resources Recommend Favorite

Hormone-related pharmacokinetic variations associated with anti-breast cancer drugs

By Li Juan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite

Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 130-147

Bentham Science Publishers

Access to resources Recommend Favorite

Drug transport by breast cancer resistance protein

By Poguntke Maren   Hazai Eszter   Fromm Martin F   Zolk Oliver  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1363-1384

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of capecitabine in breast cancer

By Daniele Gennaro   Gallo Marianna   Piccirillo Maria Carmela   Giordano Pasqualina   D'Alessio Amelia   Del Giudice Antonia   La Porta Maria Libera   Perrone Francesco   Normanno Nicola   De Luca Antonella  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 2, 2013-02 ,pp. : 225-235

Informa Healthcare

Access to resources Recommend Favorite